Loading...
OTCM
MRMD
Market cap26mUSD
Oct 08, Last price  
0.06USD
1D
0.16%
1Q
-6.47%
Jan 2017
-72.94%
IPO
-74.55%
Name

MariMed Inc

Chart & performance

D1W1MN
OTCM:MRMD chart
P/E
—
P/S
0.16
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.77%
Rev. gr., 5y
25.72%
Revenues
160m
+1.18%
125,60778590488,3841,270,1763,564,1206,067,85311,851,91545,604,64550,895,151121,464,158134,010,000148,598,000157,964,000159,826,000
Net income
-14m
L+19.07%
-377,410-809,540-535,607-7,219,541-1,215,333-198,852-1,194,083-13,604,068-66,518,0852,143,9897,225,00013,468,000-16,031,000-12,164,000-14,484,000
CFO
8m
+13.41%
-181,267-127,465-10,653-692,537-392,881-197,9321,277,075-2,907,857-24,138,3173,380,30335,854,8377,311,0007,910,0006,785,0007,695,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MariMed Inc. is a key player in the cannabis industry, involved in the cultivation, production, and distribution of both medicinal and adult-use cannabis products across the United States and internationally. The company's diverse brand portfolio includes Nature's Heritage for cannabis genetics, flowers, and concentrates, while Kalm Fusion offers cannabis-infused chewable tablets and powdered drink mixes. Its edibles segment features natural fruit chews under the Betty's Eddies brand and a variety of baked goods like brownies and cookies from Bubby's Baked. Additionally, MariMed develops cannabidiol (CBD) formulations under the Florance brand. The company further expands its operations by licensing its proprietary brands and product formulations, and by leasing cannabis-specific facilities. MariMed Inc. was founded in 2011 and maintains its headquarters in Norwood, Massachusetts.

Key people

Jon Levine
President, Chief Executive Officer · since 2024
Mario Pinho
Chief Financial Officer · since 2024
Timothy Shaw
Chief Operating Officer · since 2021
Ryan Crandall
Chief Commercial Officer · since 2025
Independent Director · since 2019
Edward Gildea
Independent Non-Executive Chairman of the Board · since 2023
Eva Selhub
Independent Director · since 2019
Kathleen Tucker
Independent Director · since 2023
IPO date
May 04, 2012
Employees
592
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT